Discovery of pyrazolo[1,5-a]pyrimidines: Synthesis, in silico insights, and anticancer activity via novel CDK2/Tubulin dual inhibition approach
Bioorganic Chemistry · 2025
DOI: 10.1016/j.bioorg.2025.108792 ↗Kurz gefasst
Fachartikel in der Zeitschrift Bioorganic Chemistry, 2025. Verfasst von Hossam R Elgiushy und 4 weiteren Autor:innen. Beteiligte Einrichtung: Biotechnology program, Faculty of Basic and Applied Sciences, Egypt-Japan University of Science and Technology (E-JUST), New Borg El-Arab City, 21934…. Hauptthemen laut MEDLINE: Antineoplastic Agents, Pyrimidines, Cyclin-Dependent Kinase 2, Tubulin. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 120 Literaturangaben. Gefördert von: Ministry of Higher Education, Egypt-Japan University of Science and Technology.
Abstract (Originalsprache)
A series of new pyrazolo[1,5-a]pyrimidine derivatives was designed and synthesized as dual CDK2/tubulin polymerization inhibitors. MTT cytotoxicity assay was conducted against five cancer cell lines and one normal cell line. Compounds 6h, and 6q displayed the highest antiproliferative activity, with average IC50 values of 7.01 and 17.37 μM, respectively, against the tested cancer cell lines. MDA-MB-231 triple-negative breast cancer (TNBC) cells were the most sensitive cell lines to 6q and 6h with IC50 values of 6.44 and 12.75 μM, respectively. Cell cycle analysis of MDA-MB-231 cells post-treatment with 6h and 6q revealed remarkable arrest at S/G2-M transition. Both compounds increased the total apoptotic population in MDA-MB-231 apoptosis detection flowcytometry assay. Evaluation of apoptotic markers through ELISA assays of intrinsic pathway markers; P53, Bax, Bcl-2, cytochrome-c, caspase-9, extrinsic pathway markers; caspase-8 and the executioner caspase-3 showed activation of both intrinsic and extrinsic pathways in apoptosis induction. Both compounds were able to inhibit cyclin-dependent kinase-2 CDK2/Cyclin A in enzyme assay with IC50 values of 3.41 ± 0.15 and 6.37 ± 0.41 μM for 6q and 6h, respectively. Tubulin polymerization kinetic assay disclosed that compound 6h was able to inhibit tubulin polymerization by 70.9 % a more potent effect compared to 45.7 % for colchicine indicating CDK2/Tubulin dual Inhibition properties. The effect of 6h was further confirmed by its effect on reducing detectable β-tubulin levels by 43 %. Density functional theory (DFT) computational studies were performed to explain the electronic arrangement, energy gap and reactivity descriptors of compounds 6h and 6q. Molecular docking manifested strong interaction of both 6h and 6q with catalytic residues of CDK2 binding pocket with binding scores of -7.0582 and -6.3965 kcal/mol, respectively. Molecular docking of 6h at the tubulin colchicine binding site CBS disclosed strong multiple interactions with both α and β tubulin residues with a binding score of -7.61 kcal/mol. ADME prediction study predicted favorable pharmacokinetic properties. Both 6h and 6q provided the basis for the development of a more potent series of pyrazolo[1,5-a] pyrimidine-based CDK2/tubulin dual inhibitors.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Biotechnology program, Faculty of Basic and Applied Sciences, Egypt-Japan University of Science and Technology (E-JUST), New Borg El-Arab City, 21934 Alexandria, Egypt; Pharmaceutical Chemistry Department, Faculty of Ph…
- Department of Pharmaceutics and Industrial Pharmacy, Faculty of Pharmacy, Ain Shams University, Abbassia, 11566 Cairo, Egypt; PharmD program, Egypt-Japan University of Science and Technology (E-JUST), New Borg El-Arab C…
- Nanoscience Program, Faculty of Basic and Applied Sciences, Egypt-Japan University of Science and Technology (E-JUST), New Borg El-Arab City, 21934 Alexandria, Egypt.
- Pharmaceutical Chemistry Department, Faculty of Pharmacy, Ain Shams University, Abbassia, 11566 Cairo, Egypt. Electronic address: khaled.abouzid@pharma.asu.edu.eg.
- Pharmaceutical Chemistry Department, Faculty of Pharmacy, Helwan University, Ain Helwan, 11795 Cairo, Egypt; PharmD program, Egypt-Japan University of Science and Technology (E-JUST), New Borg El-Arab City, 21934 Alexan…
Förderung
- Ministry of Higher Education
- Egypt-Japan University of Science and Technology
Zitieren
APA
Elgiushy, H. R., Soliman, M. E., El-Khouly, M. E., Abouzid, K. A. M., & Hammad, S. F. (2025). Discovery of pyrazolo[1,5-a]pyrimidines: Synthesis, in silico insights, and anticancer activity via novel CDK2/Tubulin dual inhibition approach. Bioorganic Chemistry. https://doi.org/10.1016/j.bioorg.2025.108792
Vancouver
Elgiushy HR, Soliman ME, El-Khouly ME, Abouzid KAM, Hammad SF. Discovery of pyrazolo[1,5-a]pyrimidines: Synthesis, in silico insights, and anticancer activity via novel CDK2/Tubulin dual inhibition approach. Bioorganic Chemistry. 2025. doi:10.1016/j.bioorg.2025.108792
BibTeX
@article{Elgiushy2025,
author = {Elgiushy, Hossam R and Soliman, Mahmoud E and El-Khouly, Mohamed E and Abouzid, Khaled A M and Hammad, Sherif F},
title = {Discovery of pyrazolo[1,5-a]pyrimidines: Synthesis, in silico insights, and anticancer activity via novel CDK2/Tubulin dual inhibition approach},
journal = {Bioorganic Chemistry},
year = {2025},
doi = {10.1016/j.bioorg.2025.108792}
}
EUVIMED